Mesoglycan for long-term secondary prevention in patients with superficial vein thrombosis (METRO): a multicentre randomised clinical trial in Italy
EClinicalMedicine · Published 2026-07-01 · DOI 10.1016/j.eclinm.2026.104010
Free full text
Authors (56)
Giuseppe Camporese, Enrico Bernardi, Cristiano Bortoluzzi, Franco Noventa, Ambra Sammarco, Chiara Tonello, Beniamino Zalunardo, Corrado Amato, Cecilia Becattini, Ornella Barbato, Angelo Santoliquido, Nello Zanatta, Domenico Angiletta, Francesco Dentali, Daniela Mastroiacovo, Walter Dorigo, Oriana Zingaretti, Maria Amitrano, Roberto Catalini, Antonella Tufano, Pierpaolo Di Micco, Dimitrios Kontothanassis, Paolo Simioni, Paolo Prandoni, Elena Campello, Raffaele Pesavento, Luca Spiezia, Chiara Simion, Paolo Scarinzi, Ngoc Vo Hong, Michela Nardin, Sara Maggiolo, Adriana Visonà, Paola Bigolin, Tatiana Scanduzzi Piovesan, Ida Maria Muratori, Francesco Contorno, Francesco Sartore, Laura Franco, Mara Graziani, Luca Santoro, Sergio Zacà, Lucia Di Stefano, Alessia Abenante, Benedetta Volpe, Silvia Frasca, Mauro Pinelli, Laura Giantomassi, Vincenza Pedone, Federica Dimitri, Raffaele Pulli, Laura Paperetti, Alessandro Saturni, Sara Mangiacapra, Francesca Cannavacciuolo, Giovanni Di Minno
Abstract
PubPorta does not have an abstract for this article yet.
Read the article at the publisher →
Publication details
- Year
- 2026
Citation
Camporese, G., Bernardi, E., Bortoluzzi, C., et al. (2026). Mesoglycan for long-term secondary prevention in patients with superficial vein thrombosis (METRO): a multicentre randomised clinical trial in Italy. EClinicalMedicine. https://doi.org/10.1016/j.eclinm.2026.104010
Related articles
- Machine learning for diagnosing non-ST-segment elevation myocardial infarction: a derivation and validation study · EClinicalMedicine · 2026 · Same journal
- Potential preventive role of low-dose methotrexate against incident recorded psychosis: a retrospective cohort study based on electronic health records · EClinicalMedicine · 2026 · Same journal
- Eye movement desensitisation and reprocessing for post-traumatic stress in survivors of critical illness (EMERALD): a mixed-methods, randomised, single-blind, parallel group-controlled, feasibility trial · EClinicalMedicine · 2026 · Same journal
- A deep learning model for opportunistic screening of chronic kidney disease using chest radiographs: a multicentre validation study in the USA · EClinicalMedicine · 2026 · Same journal
- Remote programming versus standard in-person programming following deep brain stimulation in patients with Parkinson’s disease: a randomised controlled trial · EClinicalMedicine · 2026 · Same journal
- High-frequency irreversible electroporation versus transurethral resection of the prostate for benign prostatic hyperplasia (GIANT): a single-centre, randomised, double-blind, phase 3, non-inferiority trial · EClinicalMedicine · 2026 · Same journal
- The effect of normothermic machine perfusion on acute kidney injury following liver transplantation: a propensity score-matched, retrospective, single-centre, cohort study · EClinicalMedicine · 2026 · Same journal
- Naming disease, shaping care: patient perspectives matter · EClinicalMedicine · 2026 · Same journal
- Development and independent validation of a hypoxemia risk prediction model (HAPPY-12K) for sedated gastrointestinal endoscopy: a multicentre prospective cohort study · EClinicalMedicine · 2026 · Same journal
- Expression of concern—Donor characteristics and their impact on kidney transplantation outcomes: results from two nationwide instrumental variable analyses based on outcomes of donor kidney pairs accepted for transplantation · EClinicalMedicine · 2026 · Same journal